Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;10(7):715-724.
doi: 10.1016/S2213-2600(22)00169-2. Epub 2022 Jun 14.

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

Collaborators, Affiliations
Review

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

Daniel Munblit et al. Lancet Respir Med. 2022 Jul.

Abstract

Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a growing global health challenge. Research on post-COVID-19 condition is expanding but, at present, no agreement exists on the health outcomes that should be measured in people living with the condition. To address this gap, we conducted an international consensus study, which included a comprehensive literature review and classification of outcomes for post-COVID-19 condition that informed a two-round online modified Delphi process followed by an online consensus meeting to finalise the core outcome set (COS). 1535 participants from 71 countries were involved, with 1148 individuals participating in both Delphi rounds. Eleven outcomes achieved consensus for inclusion in the final COS: fatigue; pain; post-exertion symptoms; work or occupational and study changes; survival; and functioning, symptoms, and conditions for each of cardiovascular, respiratory, nervous system, cognitive, mental health, and physical outcomes. Recovery was included a priori because it was a relevant outcome that was part of a previously published COS on COVID-19. The next step in this COS development exercise will be to establish the instruments that are most appropriate to measure these core outcomes. This international consensus-based COS should provide a framework for standardised assessment of adults with post-COVID-19 condition, aimed at facilitating clinical care and research worldwide.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests DM is a co-chair of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) Global Paediatric Long COVID working group and a member of the ISARIC working group on long-term follow-up in adults. CA reports grants or contracts from Dr Wolff Group, Bionorica, and The European Cooperation in Science and Technology; consulting fees from the Dr Wolff Group, Bionorica, and Sanofi-Aventis Germany; and honoraria from AstraZeneca. SLG is the project coordinator of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative. PRW is chair of the COMET Management Group. All other authors declare no competing interests.

Figures

Figure
Figure
Overview of the COS development process For the Delphi survey, all outcomes from the first round were included in the second round. COMET=Core Outcome Measures in Effectiveness Trials. COS=core outcome set. *Outcomes were classified using COMET taxonomy. †Outcomes were classified into survival, physiological or clinical, life impact, and resource use outcomes. ‡Participants were classified into three stakeholder groups: people with post-COVID-19 condition and family members or caregivers, health-care professionals and researchers with post-COVID-19 condition, and health-care professionals and researchers without post-COVID-19 condition. §Participants were classified into two stakeholder groups: people with post-COVID-19 condition and family members or caregivers, and health-care professionals and researchers without post-COVID-19 condition. ¶Additional outcome was part of a previously published COS for COVID-19.

Comment in

  • Post-COVID-19 condition in children: a COS is urgently needed.
    Munblit D, Buonsenso D, Sigfrid L, Vijverberg SJH, Brackel CLH. Munblit D, et al. Lancet Respir Med. 2022 Jul;10(7):628-629. doi: 10.1016/S2213-2600(22)00211-9. Epub 2022 Jun 14. Lancet Respir Med. 2022. PMID: 35714657 Free PMC article. No abstract available.
  • The COVID-19 continuum of illness.
    Herridge MS, Azoulay É. Herridge MS, et al. Lancet Respir Med. 2022 Jul;10(7):630-631. doi: 10.1016/S2213-2600(22)00219-3. Epub 2022 Jun 15. Lancet Respir Med. 2022. PMID: 35716674 Free PMC article. No abstract available.

References

    1. Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747–758. - PMC - PubMed
    1. Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6 - PMC - PubMed
    1. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102–e107. - PMC - PubMed
    1. Miyar J, Adams CE. Content and quality of 10,000 controlled trials in schizophrenia over 60 years. Schizophr Bull. 2013;39:226–229. - PMC - PubMed
    1. Gargon E, Gorst SL, Matvienko-Sikar K, Williamson PR. Choosing important health outcomes for comparative effectiveness research: 6th annual update to a systematic review of core outcome sets for research. PLoS One. 2021;16 - PMC - PubMed

Publication types